Sepsis Market Analysis: Key Insights on Growth Rates, Trends, and Major Opportunities
Get 20% off on Global Market Reports until March 31st! Use code FY25SAVE at checkout.
How has the market grown over the years?
The scale of the sepsis market has been expanding robustly over the past few years. Its projected growth is from $0.93 billion in 2024 to $1.02 billion in 2025, thanks to a compound annual growth rate (CAGR) of 9.3%. Factors contributing to the historical growth include an increase in sepsis cases due to older populations, a surge in chronic diseases, enhanced awareness among healthcare providers, an uptick in healthcare expenses, and the implementation of governmental campaigns for early detection and handling of sepsis.
What Is the forecasted market size and growth rate for the market?
The forecast for the sepsis market presents a promising picture, with the market set to expand to $1.44 billion in 2029 at a compound annual growth rate (CAGR) of 9.0%. Several factors are contributing to this expected growth, such as the increased use of artificial intelligence in critical care, a rising number of multidrug-resistant infections, increased awareness and education about sepsis, growth of healthcare facilities in emerging economies, and enhanced investment in biotech and pharma research. Key trends that will define this forecast period include the development of fast point-of-care diagnostics, the adoption of predictive analytics powered by AI, personalized antibiotic stewardship programs, progress in blood culture methods, innovations in biomarker identification, and the creation of novel therapies focussed on immune modulation.
Get your market report here!
https://www.thebusinessresearchcompany.com/report/sepsis-global-market-report
What main drivers are fueling expansion in the market?
The rising prevalence of infectious diseases is anticipated to fuel the expansion of the sepsis market. Infectious diseases, which can be provoked by bacteria, viruses, fungi, or parasites that invade the body, include common ailments like tuberculosis, flu, ringworm, and malaria. They can propagate through personal contact, polluted sources, or insect carriers. The rising incidence of such diseases can be attributed to various factors including population growth, globalization, environmental changes, drug-resistant pathogens, as well as weaknesses in healthcare systems. Sepsis, a severe consequence of these diseases, is a result of the body’s extreme reaction to infections, causing intense inflammation and the potential risk of organ failure. For example, in November 2024, the Centers for Disease Control and Prevention, a public health agency based in the U.S., reported that there were 9,633 incidents of tuberculosis in the United States in 2023, representing a 15.6% increase from the 8,332 cases reported in 2022. Hence, the escalating prevalence of infectious diseases is a significant factor propelling the growth of the sepsis market.
What key areas define the segmentation of the global Market?
The sepsis market covered in this report is segmented –
1) By Type: Diagnosis, Therapeutics
2) By Pathogen: Bacterial, Viral, Fungal
3) By Application: Severe Sepsis, Septic Shock
4) By End User: Hospitals, Pathology, Reference Laboratories
Subsegments:
1) By Diagnosis: Blood Tests, Imaging Techniques, Microbiological Culture Tests, Biomarker Tests, Other Diagnostic Methods
2) By Therapeutics: Antibiotics, Antifungal Agents, Vasopressors, Immunoglobulins, Corticosteroids, Other Therapeutic Options
Get your free sample now – explore exclusive market insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=21286&type=smp
What are the top market players propelling the growth of the industry?
Major companies operating in the sepsis market are Pfizer Inc., F. Hoffmann-La Roche AG, Merck KGaA, Bayer AG, Thermo Fisher Scientific Inc., Abbott laboratories, Novartis AG, Siemens AG, Asahi Kasei Corporation, Becton, Dickinson and Company, bioMérieux SA, QuidelOrtho Corporation, Diasorin S.p.A., Innoviva Inc., Seegene Inc., EKF Diagnostics, Boditech Med Inc., Cytovale Inc., Alifax S.r.l., Hansa Biopharma, Amomed Pharma GmbH, Inotrem S.A., Abionic SA, Biosystems Inc., Immunexpress Inc.
What are the key trends shaping the future of the market?
Prominent organizations in the sepsis market are striving to develop advanced technological platforms, such as those powered by artificial intelligence (AI), to improve early detection, increase treatment accuracy, and forecast patient results with the ultimate objective of reducing death rates and enhancing healthcare efficacy in handling sepsis. For instance, in June 2024, Predicate Healthcare Performance Group (HPG), a healthcare company located in the United States, introduced OpenDX, its AI-based software platform. This inventive platform integrates AI-enabled diagnostics with wearable biosensors, thereby assisting healthcare practitioners in spotting early indications of sepsis. This contributes to the diagnosis of sepsis and has the potential to apply to other medical conditions, underlining the significance of technology in diagnostic processes. Predicate’s thoracic sensor enables healthcare professionals to identify early symptoms of sepsis, a diagnosis that is often tricky and overlooked.
Unlock exclusive market insights – purchase your research report now for a swift delivery!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=21286
What regions are dominating the market growth?
North America was the largest region in the sepsis market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the sepsis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Browse Through More Similar Reports By The Business Research Company:
Hospital-Acquired Infection Control Global Market Report 2025
Infection Prevention Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/infection-prevention-global-market-report
Yeast Infection Treatment Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/yeast-infection-treatment-global-market-report
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
